BDTX FY 2022 Earnings — Black Diamond Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

BDTXBlack Diamond Therapeutics, Inc.

$126M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$93M

Net Income

-$91M

EPS (Diluted)

$-2.52

Cash Flow

Operating Cash Flow

-$85M

Free Cash Flow

-$85M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$156M

Total Liabilities

$41M

Stockholders' Equity

$116M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$93M	-$127M	+26.8%
Net Income	-$91M	-$126M	+27.4%